SCHEMBL7962733

SCHEMBL7962733

CC(=O)c1ccc(OC(O)CCN2CCC(O)(c3cnc4ccccc4c3)CC2)c(C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 6/20 0.39
MAP4K4 O95819 1/20 0.36
CSNK1G2 P78368 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36
MAP4K5 Q9Y4K4 1/20 0.36
HTR1A P08908 1/20 0.35
DRD2 P14416 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
DRD3 P35462 1/20 0.35
OPRL1 P41146 1/20 0.35
FASN P49327 1/20 0.34
CHRNB2 P17787 1/20 0.34
CHRNA7 P36544 1/20 0.34
CHRNA4 P43681 1/20 0.34
TACR2 P21452 2/20 0.34
TACR1 P25103 2/20 0.34
CCR1 P32246 1/20 0.34
NOTUM Q6P988 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7953304 0.89 OPRL1 (0.38) ABCB1HTR1AOPRL1TACR2
SCHEMBL7953494 0.86 ABCB1 (0.41) ABCB1DRD2DRD3OPRL1CCR1
SCHEMBL7969776 0.86 OPRL1 (0.35) ABCB1HTR1ADRD2HTR2AHTR2C
SCHEMBL7962728 0.85 ABCB1 (0.54) ABCB1
SCHEMBL7966030 0.84 ABCB1 (0.38) ABCB1HTR1ADRD2HTR2AOPRL1
SCHEMBL7953684 0.83 OPRL1 (0.36) ABCB1HTR1AOPRL1TACR2
SCHEMBL7964376 0.83 ABCB1 (0.44) ABCB1DRD2DRD3OPRL1TACR2
SCHEMBL7969481 0.83 LTA4H (0.38) ABCB1HTR1ADRD2DRD3OPRL1
SCHEMBL7953964 0.83 HTR1A (0.40) ABCB1HTR1ADRD2HTR2AHTR2C
SCHEMBL7962723 0.83 MAP4K4 (0.36) ABCB1MAP4K4CSNK1G2CLK4MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6242450-B1 SUBSTITUTED PIPERIDINES ELI LILLY AND COMPANY 2001-06-05 US disclosed
WO-2000006082-A2 TREATMENT OF ANXIETY DISORDERS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
WO-2000006166-A1 5-HT1F ANTAGONISTS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
EP-0976746-A1 5-HT1F antagonists ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed
EP-0976747-A2 Use of 5HT-1F receptor antagonists for treating anxiety disorders ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed